AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
A PHASE-I STUDY OF HUMAN GAMMA-INTERFERON GENE-TRANSDUCED TUMOR-CELLSIN PATIENTS WITH NEUROBLASTOMA
Authors: SEEGER RC ROSENBLATT JD DUERST RE REYNOLDS CP VILLABLANCA JG HASENAUER B FEIG SA
Citation: Rc. Seeger et al., A PHASE-I STUDY OF HUMAN GAMMA-INTERFERON GENE-TRANSDUCED TUMOR-CELLSIN PATIENTS WITH NEUROBLASTOMA, Human gene therapy, 9(3), 1998, pp. 379-390
SUCCESSFUL TREATMENT OF STAGE-III NEUROBLASTOMA BASED ON PROSPECTIVE BIOLOGIC STAGING - A CHILDRENS CANCER GROUP-STUDY
Authors: MATTHAY KK PEREZ C SEEGER RC BRODEUR GM SHIMADA H ATKINSON JB BLACK CT GERBING R HAASE GM STRAM DO SWIFT P LUKENS JN
Citation: Kk. Matthay et al., SUCCESSFUL TREATMENT OF STAGE-III NEUROBLASTOMA BASED ON PROSPECTIVE BIOLOGIC STAGING - A CHILDRENS CANCER GROUP-STUDY, Journal of clinical oncology, 16(4), 1998, pp. 1256-1264
DOUBLE-ALKYLATOR NON-TOTAL-BODY IRRADIATION REGIMEN WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PEDIATRIC SOLID TUMORS
Authors: OZKAYNAK MF MATTHAY K CAIRO M HARRIS RE FEIG S REYNOLDS CP BUCKLEY J VILLABLANCA JG SEEGER RC
Citation: Mf. Ozkaynak et al., DOUBLE-ALKYLATOR NON-TOTAL-BODY IRRADIATION REGIMEN WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PEDIATRIC SOLID TUMORS, Journal of clinical oncology, 16(3), 1998, pp. 937-944
PHASE-I DOSE-ESCALATION OF I-131 METAIODOBENZYLGUANIDINE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN REFRACTORY NEUROBLASTOMA
Authors: MATTHAY KK DESANTES K HASEGAWA B HUBERTY J HATTNER RS ABLIN A REYNOLDS CP SEEGER RC WEINBERG VK PRICE D
Citation: Kk. Matthay et al., PHASE-I DOSE-ESCALATION OF I-131 METAIODOBENZYLGUANIDINE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN REFRACTORY NEUROBLASTOMA, Journal of clinical oncology, 16(1), 1998, pp. 229-236
ENGRAFTMENT AFTER MYELOABLATIVE DOSES OF I-131 METAIODOBENZYLGUANIDINE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF REFRACTORY NEUROBLASTOMA
Authors: GOLDBERG SS DESANTES K HUBERTY JP PRICE D HASEGAWA BH REYNOLDS CP SEEGER RC HATTNER R MATTHAY KK
Citation: Ss. Goldberg et al., ENGRAFTMENT AFTER MYELOABLATIVE DOSES OF I-131 METAIODOBENZYLGUANIDINE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF REFRACTORY NEUROBLASTOMA, Medical and pediatric oncology, 30(6), 1998, pp. 339-346
MATRIX-METALLOPROTEINASES-2 AND MATRIX-METALLOPROTEINASES-9 ARE EXPRESSED IN HUMAN NEUROBLASTOMA - CONTRIBUTION OF STROMAL CELLS TO THEIR PRODUCTION AND CORRELATION WITH METASTASIS
Authors: SUGIURA Y SHIMADA H SEEGER RC LAUG WE DECLERCK YA
Citation: Y. Sugiura et al., MATRIX-METALLOPROTEINASES-2 AND MATRIX-METALLOPROTEINASES-9 ARE EXPRESSED IN HUMAN NEUROBLASTOMA - CONTRIBUTION OF STROMAL CELLS TO THEIR PRODUCTION AND CORRELATION WITH METASTASIS, Cancer research, 58(10), 1998, pp. 2209-2216
TELOMERASE EXPRESSION IN PRIMARY NEUROBLASTOMAS
Authors: REYNOLDS CP ZUO JJ KIM NW WANG H LUKENS JN MATTHAY KK SEEGER RC
Citation: Cp. Reynolds et al., TELOMERASE EXPRESSION IN PRIMARY NEUROBLASTOMAS, European journal of cancer, 33(12), 1997, pp. 1929-1931
DRUG-RESISTANCE IN HUMAN NEUROBLASTOMA CELL-LINES CORRELATES WITH CLINICAL-THERAPY
Authors: KESHELAVA N SEEGER RC REYNOLDS CP
Citation: N. Keshelava et al., DRUG-RESISTANCE IN HUMAN NEUROBLASTOMA CELL-LINES CORRELATES WITH CLINICAL-THERAPY, European journal of cancer, 33(12), 1997, pp. 2002-2006
THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT
Authors: CASTLEBERRY RP PRITCHARD J AMBROS P BERTHOLD F BRODEUR GM CASTEL V COHN SL DEBERNARDI B DICKSMIREAUX C FRAPPAZ D HAASE GM HABER M JONES DR JOSHI VV KANEKO M KEMSHEAD JT KOGNER P LEE REJ MATTHAY KK MICHON JM MONCLAIR R ROALD BR SEEGER RC SHAW PJ SHIMADA H SHUSTER JJ
Citation: Rp. Castleberry et al., THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT, European journal of cancer, 33(12), 1997, pp. 2113-2116
QUANTITATION OF TRK-A MESSENGER-RNA BY RT-PCR IDENTIFIES BIOLOGICALLYAND CLINICALLY DISTINCT SUBSETS OF NEUROBLASTOMA
Authors: PETERS J SEEGER RC CAI B YAO D HONG CM LUKENS J MATTHAY KK STRAM DO SHIMADA H
Citation: J. Peters et al., QUANTITATION OF TRK-A MESSENGER-RNA BY RT-PCR IDENTIFIES BIOLOGICALLYAND CLINICALLY DISTINCT SUBSETS OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2139-2139
ANTINEURONAL ANTIBODIES IN PATIENTS WITH NEUROBLASTOMA AND PARANEOPLASTIC OPSOCLONUS-MYOCLONUS
Authors: ANTUNES NL KHAKOO Y STRAM DO SEEGER RC MATTHAY KK DALMAU J
Citation: Nl. Antunes et al., ANTINEURONAL ANTIBODIES IN PATIENTS WITH NEUROBLASTOMA AND PARANEOPLASTIC OPSOCLONUS-MYOCLONUS, Annals of neurology, 42(3), 1997, pp. 128-128
WILD-TYPE DNA-SEQUENCE OF THE N-MYC TRANSACTIVATION DOMAIN IN HUMAN NEUROBLASTOMA
Authors: FENG L MIYAKE M SEEGER RC BOGENMANN E
Citation: L. Feng et al., WILD-TYPE DNA-SEQUENCE OF THE N-MYC TRANSACTIVATION DOMAIN IN HUMAN NEUROBLASTOMA, International journal of cancer, 71(6), 1997, pp. 1116-1117
A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/
Authors: FROST JD HANK JA REAMAN GH FRIERDICH S SEEGER RC GAN J ANDERSON PM ETTINGER LJ CAIRO MS BLAZAR BR KRAILO MD MATTHAY KK REISFELD RA SONDEL PM
Citation: Jd. Frost et al., A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/, Cancer, 80(2), 1997, pp. 317-333
NEUROBLASTOMA IN ADULTS AND ADOLESCENTS - AN INDOLENT COURSE WITH POOR SURVIVAL
Authors: FRANKS LM BOLLEN A SEEGER RC STRAM DO MATTHAY KK
Citation: Lm. Franks et al., NEUROBLASTOMA IN ADULTS AND ADOLESCENTS - AN INDOLENT COURSE WITH POOR SURVIVAL, Cancer, 79(10), 1997, pp. 2028-2035
GAIN OF CHROMOSOME-17 IS THE MOST FREQUENT ABNORMALITY DETECTED IN NEUROBLASTOMA BY COMPARATIVE GENOMIC HYBRIDIZATION
Authors: PLANTAZ D MOHAPATRA G MATTHAY KK PELLARIN M SEEGER RC FEUERSTEIN BG
Citation: D. Plantaz et al., GAIN OF CHROMOSOME-17 IS THE MOST FREQUENT ABNORMALITY DETECTED IN NEUROBLASTOMA BY COMPARATIVE GENOMIC HYBRIDIZATION, The American journal of pathology, 150(1), 1997, pp. 81-89
CONSOLIDATION CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONTINUED CHEMOTHERAPY FOR METASTATIC NEUROBLASTOMA - A REPORT OF 2 CONCURRENT CHILDRENS CANCER GROUP STUDIES
Authors: STRAM DO MATTHAY KK OLEARY M REYNOLDS CP HAASE GM ATKINSON JB BRODEUR GM SEEGER RC
Citation: Do. Stram et al., CONSOLIDATION CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONTINUED CHEMOTHERAPY FOR METASTATIC NEUROBLASTOMA - A REPORT OF 2 CONCURRENT CHILDRENS CANCER GROUP STUDIES, Journal of clinical oncology, 14(9), 1996, pp. 2417-2426
IDENTIFICATION OF SUBSETS OF NEUROBLASTOMAS BY COMBINED HISTOPATHOLOGIC AND N-MYC ANALYSIS
Authors: SHIMADA H STRAM DO CHATTEN J JOSHI VV HACHITANDA Y BRODEUR GM LUKENS JN MATTHAY KK SEEGER RC
Citation: H. Shimada et al., IDENTIFICATION OF SUBSETS OF NEUROBLASTOMAS BY COMBINED HISTOPATHOLOGIC AND N-MYC ANALYSIS, Journal of the National Cancer Institute, 87(19), 1995, pp. 1470-1476
PELVIC NEUROBLASTOMA-IMPLICATIONS FOR A NEW FAVORABLE SUBGROUP - A CHILDRENS CANCER GROUP EXPERIENCE
Authors: HAASE GM OLEARY MC STRAM DO LUKENS JN SEEGER RC SHIMADA H MATTHAY KK
Citation: Gm. Haase et al., PELVIC NEUROBLASTOMA-IMPLICATIONS FOR A NEW FAVORABLE SUBGROUP - A CHILDRENS CANCER GROUP EXPERIENCE, Annals of surgical oncology, 2(6), 1995, pp. 516-523
ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS
Authors: MATTHAY KK OLEARY MC RAMSAY NK VILLABLANCA J REYNOLDS CP ATKINSON JB HAASE GM STRAM DO SEEGER RC
Citation: Kk. Matthay et al., ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS, European journal of cancer, 31A(4), 1995, pp. 572-575
SUSTAINED CYTOKINE PRODUCTION AND IMMUNOPHENOTYPIC CHANGES IN HUMAN NEUROBLASTOMA CELL-LINES TRANSDUCED WITH A HUMAN GAMMA-INTERFERON VECTOR
Authors: UCAR K SEEGER RC CHALLITA PM WATANABE CT YEN TL MORGAN JP AMADO R CHOU E MCCALLISTER T BARBER JR JOLLY DJ REYNOLDS CP GANGAVALLI R ROSENBLATT JD
Citation: K. Ucar et al., SUSTAINED CYTOKINE PRODUCTION AND IMMUNOPHENOTYPIC CHANGES IN HUMAN NEUROBLASTOMA CELL-LINES TRANSDUCED WITH A HUMAN GAMMA-INTERFERON VECTOR, Cancer gene therapy, 2(3), 1995, pp. 171-181
PHASE-I TRIAL OF 13-CIS-RETINOIC ACID IN CHILDREN WITH NEUROBLASTOMA FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: VILLABLANCA JG KHAN AA AVRAMIS VI SEEGER RC MATTHAY KK RAMSAY NKC REYNOLDS CP
Citation: Jg. Villablanca et al., PHASE-I TRIAL OF 13-CIS-RETINOIC ACID IN CHILDREN WITH NEUROBLASTOMA FOLLOWING BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 13(4), 1995, pp. 894-901
SPLICING PATTERN OF THE HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (TRKA) TRANSCRIPT IN NEUROBLASTOMAS - CORRELATION WITH HISTOPATHOLOGY AND CLINICAL OUTCOME
Authors: PETERS J MIYAKE N SEEGER RC CAI B YAO D HONG CM LUKENS J MATTHAY KK SHIMADA H
Citation: J. Peters et al., SPLICING PATTERN OF THE HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTOR (TRKA) TRANSCRIPT IN NEUROBLASTOMAS - CORRELATION WITH HISTOPATHOLOGY AND CLINICAL OUTCOME, Laboratory investigation, 72(1), 1995, pp. 144-144
LACK OF CORRELATION OF N-MYC GENE AMPLIFICATION WITH PROGNOSIS IN LOCALIZED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: COHN SL LOOK AT JOSHI VV HOLBROOK T SALWEN H CHAGNOVICH D CHESLER L ROWE ST VALENTINE MB KOMURO H CASTLEBERRY RP BOWMAN LC RAO PV SEEGER RC BRODEUR GM
Citation: Sl. Cohn et al., LACK OF CORRELATION OF N-MYC GENE AMPLIFICATION WITH PROGNOSIS IN LOCALIZED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Cancer research, 55(4), 1995, pp. 721-726
MAINTENANCE OF NORMAL IMPRINTING OF H19 AND IGF2 GENES IN NEUROBLASTOMA
Authors: WADA M SEEGER RC MIZOGUCHI H KOEFFLER HP
Citation: M. Wada et al., MAINTENANCE OF NORMAL IMPRINTING OF H19 AND IGF2 GENES IN NEUROBLASTOMA, Cancer research, 55(15), 1995, pp. 3386-3388
HSP27 EXPRESSION IN NEUROBLASTOMA - CORRELATION WITH DISEASE STAGE
Authors: UNGAR DR HAILAT N STRAHLER JR KUICK RD BRODEUR GM SEEGER RC REYNOLDS CP HANASH SM
Citation: Dr. Ungar et al., HSP27 EXPRESSION IN NEUROBLASTOMA - CORRELATION WITH DISEASE STAGE, Journal of the National Cancer Institute, 86(10), 1994, pp. 780-784
Risultati: 1-25 | 26-34